The many paths to p38 mitogen-activated protein kinase activation in the immune system (original) (raw)

• Crews, C. M., Alessandrini, A. A. & Erikson, R. L. Mouse Erk-1 gene product is a serine/threonine protein kinase that has the potential to phosphorylate tyrosine. Proc. Natl Acad. Sci. USA 88, 8845–8849 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Ono, K. & Han, J. The p38 signal transduction pathway: activation and function. Cell. Signal. 12, 1–13 (2000).
  Article CAS PubMed Google Scholar
• Freshney, N. W. et al. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 78, 1039–1049 (1994).
  Article CAS PubMed Google Scholar
• Rouse, J. et al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78, 1027–1037 (1994).
  Article CAS PubMed Google Scholar
• Raingeaud, J. et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270, 7420–7426 (1995).
  Article CAS PubMed Google Scholar
• Hannigan, M., Zhan, L., Ai, Y. & Huang, C. K. The role of p38 MAP kinase in TGF-β1-induced signal transduction in human neutrophils. Biochem. Biophys. Res. Commun. 246, 55–58 (1998).
  Article CAS PubMed Google Scholar
• Wilson, K. P. et al. Crystal structure of p38 mitogen-activated protein kinase. J. Biol. Chem. 271, 27696–27700 (1996).
  Article CAS PubMed Google Scholar
• Canagarajah, B. J., Khokhlatchev, A., Cobb, M. H. & Goldsmith, E. J. Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell 90, 859–869 (1997).
  Article CAS PubMed Google Scholar
• Bellon, S., Fitzgibbon, M. J., Fox, T., Hsiao, H. M. & Wilson, K. P. The structure of phosphorylated p38γ is monomeric and reveals a conserved activation-loop conformation. Structure 7, 1057–1065 (1999).
  Article CAS PubMed Google Scholar
• Songyang, Z. et al. A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol. Cell. Biol. 16, 6486–6493 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Han, J., Lee, J. D., Bibbs, L. & Ulevitch, R. J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265, 808–811 (1994).
  Article CAS PubMed Google Scholar
• Jiang, Y. et al. Characterization of the structure and function of a new mitogen-activated protein kinase (p38β). J. Biol. Chem. 271, 17920–17926 (1996).
  Article CAS PubMed Google Scholar
• Li, Z., Jiang, Y., Ulevitch, R. J. & Han, J. The primary structure of p38γ: a new member of p38 group of MAP kinases. Biochem. Biophys. Res. Commun. 228, 334–340 (1996).
  Article CAS PubMed Google Scholar
• Kumar, S. et al. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem. Biophys. Res. Commun. 235, 533–538 (1997).
  Article CAS PubMed Google Scholar
• Hale, K. K., Trollinger, D., Rihanek, M. & Manthey, C. L. Differential expression and activation of p38 mitogen-activated protein kinase α, β, γ, and δ in inflammatory cell lineages. J. Immunol. 162, 4246–4252 (1999).
  CAS PubMed Google Scholar
• Wu, J. J. & Bennett, A. M. Essential role for mitogen-activated protein (MAP) kinase phosphatase-1 in stress-responsive MAP kinase and cell survival signaling. J. Biol. Chem. 280, 16461–16466 (2005).
  Article CAS PubMed Google Scholar
• Takekawa, M. et al. p53-inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J. 19, 6517–6526 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Cheung, P. C., Campbell, D. G., Nebreda, A. R. & Cohen, P. Feedback control of the protein kinase TAK1 by SAPK2a/p38α. EMBO J. 22, 5793–5805 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, J. C., Kassis, S., Kumar, S., Badger, A. & Adams, J. L. p38 mitogen-activated protein kinase inhibitors-mechanisms and therapeutic potentials. Pharmacol. Ther. 82, 389–397 (1999).
  Article CAS PubMed Google Scholar
• Rincon, M. et al. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 17, 2817–2829 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Haeryfar, S. M. & Hoskin, D. W. Selective pharmacological inhibitors reveal differences between Thy-1- and T cell receptor-mediated signal transduction in mouse T lymphocytes. Int. Immunopharmacol. 1, 689–698 (2001).
  Article CAS PubMed Google Scholar
• Zhang, J. et al. p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells. J. Immunol. 162, 3819–3829 (1999).
  CAS PubMed Google Scholar
• Dean, J. L., Sully, G., Clark, A. R. & Saklatvala, J. The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell. Signal. 16, 1113–1121 (2004).
  Article CAS PubMed Google Scholar
• Briata, P. et al. p38-dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts. Mol. Cell 20, 891–903 (2005).
  Article CAS PubMed Google Scholar
• Hitti, E. et al. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol. Cell. Biol. 26, 2399–2407 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Parasrampuria, D. A., de Boer, P., Desai-Krieger, D., Chow, A. T. & Jones, C. R. Single-dose pharmacokinetics and pharmacodynamics of RWJ 67657, a specific p38 mitogen-activated protein kinase inhibitor: a first-in-human study. J. Clin. Pharmacol. 43, 406–413 (2003).
  Article CAS PubMed Google Scholar
• Fijen, J. W. et al. Inhibition of p38 mitogen-activated protein kinase: dose-dependent suppression of leukocyte and endothelial response after endotoxin challenge in humans. Crit. Care Med. 30, 841–845 (2002).
  Article CAS PubMed Google Scholar
• Branger, J. et al. Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. J. Immunol. 168, 4070–4077 (2002).
  Article CAS PubMed Google Scholar
• van den Blink, B. et al. P38 mitogen activated protein kinase is involved in the downregulation of granulocyte CXC chemokine receptors 1 and 2 during human endotoxemia. J. Clin. Immunol. 24, 37–41 (2004).
  Article CAS PubMed Google Scholar
• Kumar, S., Boehm, J. & Lee, J. C. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nature Rev. Drug Discov. 2, 717–726 (2003).
  Article CAS Google Scholar
• Palladino, M. A., Bahjat, F. R., Theodorakis, E. A. & Moldawer, L. L. Anti-TNF-α therapies: the next generation. Nature Rev. Drug Discov. 2, 736–746 (2003).
  Article CAS Google Scholar
• Miwatashi, S. et al. Novel inhibitor of p38 MAP kinase as an anti-TNF-α drug: discovery of _N_-[4-[2-ethyl-4-(3-methylphenyl)-1, 3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent. J. Med. Chem. 48, 5966–5979 (2005).
  Article CAS PubMed Google Scholar
• Brancho, D. et al. Mechanism of p38 MAP kinase activation in vivo. Genes Dev. 17, 1969–1978 (2003). A genetic analysis of the roles of distinct MAPKKs in the activation of p38α by different stimuli.
  Article CAS PubMed PubMed Central Google Scholar
• Wysk, M., Yang, D. D., Lu, H. T., Flavell, R. A. & Davis, R. J. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression. Proc. Natl Acad. Sci. USA 96, 3763–3768 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Tanaka, N. et al. Differential involvement of p38 mitogen-activated protein kinase kinases MKK3 and MKK6 in T-cell apoptosis. EMBO Rep. 3, 785–791 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Lu, H. T. et al. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 18, 1845–1857 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Bulavin, D. V. et al. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J. 18, 6845–6854 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Bulavin, D. V. & Fornace, A. J. J. p38 MAP kinase's emerging role as a tumor suppressor. Adv. Cancer Res. 92, 95–118 (2004).
  Article CAS PubMed Google Scholar
• Brewer, J. A., Kanagawa, O., Sleckman, B. P. & Muglia, L. J. Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo. J. Immunol. 169, 1837–1843 (2002).
  Article CAS PubMed Google Scholar
• Suzuki, H. et al. Involvement of MKK6 in TCRαβintCD69lo: a target population for apoptotic cell death in thymocytes. FASEB J. 17, 1538–1540 (2003).
  Article CAS PubMed Google Scholar
• Rincon, M. MAP-kinase signaling pathways in T cells. Curr. Opin. Immunol. 13, 339–345 (2001).
  Article CAS PubMed Google Scholar
• Pedraza-Alva, G. et al. Activation of p38 MAP kinase by DNA double-strand breaks in V(D)J recombination induces a G2/M cell cycle checkpoint. EMBO J. 25, 763–773 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, J. C. et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739–746 (1994).
  Article CAS PubMed Google Scholar
• Kuida, K. & Boucher, D. M. Functions of MAP kinases: insights from gene-targeting studies. J. Biochem. (Tokyo) 135, 653–656 (2004).
  Article CAS Google Scholar
• Adams, R. H. et al. Essential role of p38α MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell. 6, 109–116 (2000).
  Article CAS PubMed Google Scholar
• Kim, J. M., White, J. M., Shaw, A. S. & Sleckman, B. P. MAPK p38α is dispensable for lymphocyte development and proliferation. J. Immunol. 174, 1239–1244 (2005).
  Article CAS PubMed Google Scholar
• Beardmore, V. A. et al. Generation and characterization of p38β (MAPK11) gene-targeted mice. Mol. Cell. Biol. 25, 10454–10464 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Sabio, G. et al. p38γ regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP. EMBO J. 24, 1134–1145 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Frantz, B. et al. The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding. Biochemistry 37, 13846–13853 (1998).
  Article CAS PubMed Google Scholar
• Galan, A. et al. Stimulation of p38 mitogen-activated protein kinase is an early regulatory event for the cadmium-induced apoptosis in human promonocytic cells. J. Biol. Chem. 275, 11418–11424 (2000).
  Article CAS PubMed Google Scholar
• Zhuang, S., Demirs, J. T. & Kochevar, I. E. p38 mitogen-activated protein kinase mediates bid cleavage, mitochondrial dysfunction, and caspase-3 activation during apoptosis induced by singlet oxygen but not by hydrogen peroxide. J. Biol. Chem. 275, 25939–25948 (2000).
  Article CAS PubMed Google Scholar
• Bowie, A. G. & O'Neill, L. A. Vitamin C inhibits NF-κB activation by TNF via the activation of p38 mitogen-activated protein kinase. J. Immunol. 165, 7180–7188 (2000).
  Article CAS PubMed Google Scholar
• Matsuguchi, T., Musikacharoen, T., Ogawa, T. & Yoshikai, Y. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J. Immunol. 165, 5767–5772 (2000).
  Article CAS PubMed Google Scholar
• Park, S. J. & Kim, I. S. The role of p38 MAPK activation in auranofin-induced apoptosis of human promyelocytic leukaemia HL-60 cells. Br. J. Pharmacol. 146, 506–513 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Barancik, M., Htun, P., Strohm, C., Kilian, S. & Schaper, W. Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death. J. Cardiovasc. Pharmacol. 35, 474–483 (2000).
  Article CAS PubMed Google Scholar
• Park, M. T. et al. Suppression of extracellular signal-related kinase and activation of p38 MAPK are two critical events leading to caspase-8- and mitochondria-mediated cell death in phytosphingosine-treated human cancer cells. J. Biol. Chem. 278, 50624–50634 (2003).
  Article CAS PubMed Google Scholar
• Ge, B. et al. MAPKK-independent activation of p38α mediated by TAB1-dependent autophosphorylation of p38α. Science 295, 1291–1294 (2002). This study identified TAB1 as a binding partner and activator of p38α that is independent of the classical MAPK cascade.
  Article CAS PubMed Google Scholar
• Jiang, Y. et al. Structure-function studies of p38 mitogen-activated protein kinase. Loop 12 influences substrate specificity and autophosphorylation, but not upstream kinase selection. J. Biol. Chem. 272, 11096–11102 (1997).
  Article CAS PubMed Google Scholar
• Shibuya, H. et al. TAB1: an activator of the TAK1 MAPKKK in TGF-β signal transduction. Science 272, 1179–1182 (1996).
  Article CAS PubMed Google Scholar
• Shim, J. H. et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19, 2668–2681 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Ge, B. et al. TAB1β (transforming growth factor-β-activated protein kinase 1-binding protein 1β), a novel splicing variant of TAB1 that interacts with p38α but not TAK1. J. Biol. Chem. 278, 2286–2293 (2003).
  Article CAS PubMed Google Scholar
• Tanno, M. et al. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Circ. Res. 93, 254–261 (2003).
  Article CAS PubMed Google Scholar
• Matsuyama, W., Faure, M. & Yoshimura, T. Activation of discoidin domain receptor 1 facilitates the maturation of human monocyte-derived dendritic cells through the TNF receptor associated factor 6/TGF-β-activated protein kinase 1 binding protein 1β/p38α mitogen-activated protein kinase signaling cascade. J. Immunol. 171, 3520–3532 (2003).
  Article CAS PubMed Google Scholar
• Kim, L. et al. p38 MAPK autophosphorylation drives macrophage IL-12 production during intracellular infection. J. Immunol. 174, 4178–4184 (2005).
  Article CAS PubMed Google Scholar
• Ohkusu-Tsukada, K., Tominaga, N., Udono, H. & Yui, K. Regulation of the maintenance of peripheral T-cell anergy by TAB1-mediated p38α activation. Mol. Cell. Biol. 24, 6957–6966 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Ohkusu-Tsukada, K., Tominaga, N., Udono, H. & Yui, K. Erratum: Regulation of the maintenance of peripheral T-cell anergy by TAB1 mediated p38α activation. Mol. Cell. Biol. 25, 8763 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Salojin, K. V., Zhang, J. & Delovitch, T. L. TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway. J. Immunol. 163, 844–853 (1999).
  CAS PubMed Google Scholar
• Yu, H., Leitenberg, D., Li, B. & Flavell, R. A. Deficiency of small GTPase Rac2 affects T cell activation. J. Exp. Med. 194, 915–926 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Fornace, A. J. Jr et al. Mammalian genes coordinately regulate by growth arrest signals and DNA-damaging agents. Mol. Cell. Biol. 9, 4196–4203 (1989).
  Article CAS PubMed PubMed Central Google Scholar
• Takekawa, M. & Saito, H. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 95, 521–530 (1998).
  Article CAS PubMed Google Scholar
• Zhan, Q. et al. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene 18, 2892–2900 (1999).
  Article CAS PubMed Google Scholar
• Mita, H., Tsutsui, J., Takekawa, M., Witten, E. A. & Saito, H. Regulation of MTK1/MEKK4 kinase activity by its N-terminal autoinhibitory domain and GADD45 binding. Mol. Cell. Biol. 22, 4544–4555 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Lu, B. et al. GADD45α mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells. Immunity 14, 583–590 (2001). This study used gene-targeted mice to show a link between a GADD45-family member and p38α and JNK activation in T cells and T H 1-cell differentiation.
  Article CAS PubMed Google Scholar
• Lu, B., Ferrandino, A. F. & Flavell, R. A. Gadd45β is important for perpetuating cognate and inflammatory signals in T cells. Nature Immunol. 5, 38–44 (2004).
  Article CAS Google Scholar
• Chi, H., Lu, B., Takekawa, M., Davis, R. J. & Flavell, R. A. GADD45β/GADD45γ and MEKK4 comprise a genetic pathway mediating STAT4-independent IFNγ production in T cells. EMBO J. 23, 1576–1586 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Hollander, M. C. et al. Genomic instability in _Gadd45a_-deficient mice. Nature Genet. 23, 176–184 (1999).
  Article CAS PubMed Google Scholar
• Bulavin, D. V., Kovalsky, O., Hollander, M. C. & Fornace, A. J. J. Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45 a. Mol. Cell. Biol. 23, 3859–3871 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Hildesheim, J. et al. Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Cancer Res. 62, 7305–7315 (2002).
  CAS PubMed Google Scholar
• Salvador, J. M. et al. Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity 16, 499–508 (2002).
  Article CAS PubMed Google Scholar
• Salvador, J. M., Mittelstadt, P. R., Belova, G. I., Fornace, A. J. Jr & Ashwell, J. D. The autoimmune suppressor Gadd45α inhibits the T cell alternative p38 activation pathway. Nature Immunol. 6, 396–402 (2005). The description of GADD45α as a physiological inhibitor of p38 activated by Tyr323 phosphorylation.
  Article CAS Google Scholar
• Salvador, J. M. et al. Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases. Nature Immunol. 6, 390–395 (2005). This study describes the activation of p38α and p38β by phosphorylation of Tyr323 in the absence of upstream MAPKK activation.
  Article CAS Google Scholar
• Finco, T. S., Kadlecek, T., Zhang, W., Samelson, L. E. & Weiss, A. LAT is required for TCR-mediated activation of PLCγ1 and the Ras pathway. Immunity 9, 617–626 (1998).
  Article CAS PubMed Google Scholar
• Khokhlatchev, A. V. et al. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93, 605–615 (1998).
  Article CAS PubMed Google Scholar
• Mittelstadt, P. R., Salvador, J. M., Fornace, A. J. J. & Ashwell, J. D. Activating p38 MAPK: new tricks for an old kinase. Cell Cycle 4, 1189–1192 (2005).
  Article CAS PubMed Google Scholar
• Biondi, R. M. & Nebreda, A. R. Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. Biochem. J. 372, 1–13 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Holland, P. M. & Cooper, J. A. Protein modification: docking sites for kinases. Curr. Biol. 9, R329–R331 (1999).
  Article CAS PubMed Google Scholar
• Fantz, D. A., Jacobs, D., Glossip, D. & Kornfeld, K. Docking sites on substrate proteins direct extracellular signal-regulated kinase to phosphorylate specific residues. J. Biol. Chem. 276, 27256–27265 (2001).
  Article CAS PubMed Google Scholar
• Gavin, A. C. & Nebreda, A. R. A MAP kinase docking site is required for phosphorylation and activation of p90rsk/MAPKAP kinase-1. Curr. Biol. 9, 281–284 (1999).
  Article CAS PubMed Google Scholar
• Chang, C. I., Xu, B. E., Akella, R., Cobb, M. H. & Goldsmith, E. J. Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. Mol. Cell 9, 1241–1249 (2002).
  Article CAS PubMed Google Scholar